Cellectar Biosciences, Inc. Property, Plant and Equipment, Gross
Cellectar Biosciences, Inc. (CLRB) had Property, Plant and Equipment, Gross of $1.98 million as of 2023-12-31, per its 10-K/A filed 2024-10-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2024-10-29
- 2023-12-31: Property, Plant and Equipment, Gross $1.98M.
- 2022-12-31: Property, Plant and Equipment, Gross $1.11M.
- 2021-12-31: Property, Plant and Equipment, Gross $889.27K.
- 2020-12-31: Property, Plant and Equipment, Gross $759.65K.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2023-12-31 | $1.98M 10-K/A · filed 2024-10-29 |
| 2022-12-31 | $1.11M 10-K/A · filed 2024-10-29 |
| 2021-12-31 | $889.27K 10-K · filed 2023-03-09 |
| 2020-12-31 | $759.65K 10-K · filed 2022-03-21 |
| 2019-12-31 | $744.49K 10-K · filed 2021-03-02 |
| 2018-12-31 | $724.53K 10-K · filed 2020-03-09 |
| 2017-12-31 | $6.09M 10-K · filed 2019-02-26 |
| 2016-12-31 | $5.75M 10-K · filed 2018-03-21 |
| 2015-12-31 | $5.67M 10-K · filed 2017-03-15 |
| 2014-12-31 | $5.65M 10-K/A · filed 2016-10-20 |
| 2013-12-31 | $5.63M 10-K · filed 2015-05-20 |
| 2012-12-31 | $5.49M 10-K · filed 2014-03-19 |
| 2011-12-31 | $5.40M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |